Skip to main content
Equibles
ESLA logo

ESLA · Estrella Immunopharma, Inc. · Short Interest

Track ESLA — free

Use ESLA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ESLA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.47 -0.01 (-1.47%) At close · Oct 2
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“As a result, management has determined that there is a substantial doubt about its ability to continue as a going concern. If the Company is unable to obtain adequate financing or generate significant revenue, it may be required to curtail or cease its operations.”
View the 10-Q filed Aug 13, 2026
Market Cap
$20.92M
Shares
43.50M
Volume · Oct 2 14.49K Avg daily vol (3M) 37.45K

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Pull short interest history through the short interest API or MCP →

ESLA Latest Reported Short Interest

FINRA reported 153,781 ESLA shares sold short as of the September 15, 2026 settlement date, an increase of 36,649 shares. Days to cover was 4.18 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

ESLA Short Interest Forecast

Equibles' model estimates 126,304 shares sold short for the September 30, 2026 settlement, -17.9% versus the latest reported position, with a likely range of 89,998 to 154,658 shares. This model prediction uses FINRA data through September 30, 2026; FINRA's official release is expected October 9, 2026.

Model estimate

Expected Sep 30 short interest

as of Sep 30 High confidence 80% chance it falls
126,304 -17.9% vs reported
Likely range 89,998 to 154,658 The latest estimate appears in the chart below. Official release expected Oct 9. Methodology
Short Squeeze Score
40/100
Short interest 0.4% of shares — P30 Days to cover 4.2 — P57 Price vs VWAP -33.9% — P6 Short-volume trend -4.9% — P28 Short interest change +31.3% — P88 Worst FTD 0.01% of shares — P57

Positioning score 39.9 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-09-15). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

No active listed options were found.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-10-04 19:58 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-10-15 Scheduled
    FINRA publishes Oct 26
    		 — — — —
    2026-09-30 Scheduled
    FINRA publishes Oct 9
    		 — — — —
    2026-09-15 153,781 117,132 +36,649 4.18
    2026-08-31 117,132 61,410 +55,722 3.39
    2026-08-14 61,410 48,054 +13,356 2.62
    2026-07-31 48,054 54,453 -6,399 1.04
    2026-07-15 54,453 89,082 -34,629 1.19
    2026-06-30 89,082 113,312 -24,230 2.45
    2026-06-15 113,312 82,599 +30,713 2.38
    2026-05-29 82,599 94,135 -11,536 3.06
    2026-05-15 94,135 147,543 -53,408 2.67
    2026-04-30 147,543 265,805 -118,262 3.83
    2026-04-15 265,805 626,324 -360,519 1.00
    2026-03-31 626,324 656,018 -29,694 9.85
    2026-03-13 656,018 638,651 +17,367 16.79
    2026-02-27 638,651 725,979 -87,328 16.22
    2026-02-13 725,979 943,482 -217,503 1.00
    2026-01-30 943,482 864,470 +79,012 12.63
    2026-01-15 864,470 738,819 +125,651 8.73
    2025-12-31 738,819 709,318 +29,501 8.63
    2025-12-15 709,318 551,846 +157,472 4.80
    2025-11-28 551,846 170,374 +381,472 2.76
    2025-11-14 170,374 63,002 +107,372 1.00
    2025-10-31 63,002 29,615 +33,387 1.00
    2025-10-15 29,615 26,333 +3,282 1.00

    Full FINRA short interest reporting calendar

    Showing 1–23 of 23 settlements
    Key facts CIK 1844417 CUSIP 297584104 13F (30d) 1 filings 1 filers Visit website Investor relations